Medical breakthroughs in 2018 range from new devices for sleep apnea to gene therapy for blindness, according to the Cleveland Clinic. » Read More
By: Ian Haydon, doctoral student in biochemistry, University of Washington
Patients battling cancer, cardiovascular disease, inflammation and infection may soon benefit from a new class of peptide drugs. » Read More
By: Bob Woods
Medical experts in the US are bracing for one of the worst flu seasons in history as the main strain H3N2 spreads nationwide. » Read More
Collaborative relationships with hospitals across the globe are improving patient outcomes and operational efficiencies.
Many mental health experts argue that tech is addictive and hurting our youth. Two major Apple shareholders are doing something about it.
Hearing loss afflicts tens of millions, but traditional hearing devices are limited. Medical start-ups are chasing drug breakthroughs.
Bacteria engineered by Caltech medical researchers acts like sonar inside the body so it can track disease-fighting immunotherapy cells.
The most-downloaded health apps on iPhone and Android app stores reveal where Americans are turning to take control of health issues.
Steve Pete and Reid Millius, with mirror-image genetic mutations, are helping companies develop better pain medicines.
Automakers, including Toyota, Honda and Mercedes, are testing technology to monitor drivers for illnesses like heart disease and diabetes.
Hospitals are using AI chatbots to help geriatric patients face the end of life. And they may be better at talking death than doctors.
Up to 20% of military veterans have post-traumatic stress disorder. New technologies surpass traditional VA mental illness treatment.
An Obamacare repeal could reduce the health-care options provided to veterans and place more stress on the VA health-care system.
Breakthrough antiretroviral drugs for HIV are forcing states across the U.S. to rethink criminal laws enacted during the AIDS crisis.
The 2017 Nobel Prize for Medicine went to sleep researchers who proved why using a smartphone in bed is dangerous to your health.
Obesity-related diseases are on the rise, including one destined to be the leading cause of liver transplants by 2020.
On Monday the World Health Organization released its Global Tuberculosis Report — and its plan to reduce TB incidence 80 percent by 2030.
This year may see the end of the wild poliovirus.
Research into fasting as a regular part of diet could help in the fight against food-related diseases, including heart disease and diabetes.
Pharmaceutical company Sanofi has engineered a three-pronged antibody that attacks the AIDS virus and is a roadblock for HIV infection.
A globe-trotting look at the world of investing, from developed Europe and Asia trends to the least-traveled frontier markets.
Coverage of the World Economic Forum’s annual meeting in Davos, Switzerland.
Unlock the keys to building a successful long-term financial plan: manage your money, grow your money, and protect it.
Medical breakthroughs in 2018 range from new devices for sleep apnea to gene therapy for blindness and other diseases.
Medical experts in the US are bracing for one of the worst flu seasons in history as it spreads nationwide.
Two Apple shareholders have urged the tech giant to address a major concern: Tech is addictive and hurting our youth.
A consortium representing more than 450 hospitals plan to create their own generic drug company.
Dr. Marc Harrison, Intermountain Healthcare president & CEO, discusses his hospital's plan to manufacture its own drugs as a means to combat rising drug costs.
Several major hospital systems plan to form a drug company that will provide generic drugs in short supply to the hospitals, the New York Times reports.
Funding for a program that covers 9 million kids expired. Republicans aren't rushing to extend it, Vox reports.
If you're looking after sick or elderly relatives, you may be hurting your own finances.
A private British company developing a vaccine that would be the first in the world to fight all types of flu has raised $27 million from investors including GV, the venture capital arm of Google parent Alphabet Inc.
Every decade our wellness and longevity lengthens by two years. That is about to get even better.
President Donald Trump has repeatedly condemned high drug prices, but hasn't done much to lower them one year in office.
The common thread among some of the best hedge fund performers is in-depth sector expertise.